Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Maharashtra FDA bars sale of two Cadila drugs over branding concerns
Maharashtra FDA has seized Cadila Pharmaceuticals drug stock worth Rs 2.45 crore. The action was taken due to similar branding on different active ingredients. Officials barred sales of Aciloc 150 Plus and Aciloc 300 Plus medicines. This move aims to prevent medication errors and safeguard public health. Further investigation and legal action are currently underway.
Sun Pharma secures relief in 'Pantocid' trademark dispute
Delhi High Court has halted Ahmedabad-based Finecure Pharmaceuticals from producing and selling drugs with names similar to Sun Pharma's 'Pantocid'. The court permitted Finecure to sell existing stock of 'Pantopacid' within four months, provided an affidavit detailing the inventory is filed. This decision overturns a previous ruling that had refused to grant an injunction against Finecure, highlighting significant sales disparities between the two companies.
Stock market rally: Aegis Logistics, Cupid, Akums Drugs, JB Chemicals, among 47 stocks that hit 52-week high on NSE - Upstox
Stock market rally: Aegis Logistics, Cupid, Akums Drugs, JB Chemicals, among 47 stocks that hit 52-week high on NSEUpstox
Market Trading Guide: Akums Drugs among 4 stock recommendations for Thursday
Domestic equities ended lower amid global uncertainty and caution ahead of key US inflation data. Despite market weakness, analysts remain bullish on Akums Drugs and Aditya Birla Sun Life AMC after strong technical breakouts, rising volumes and improving momentum indicators.
Akums Drugs, subsidiary Akumentis Healthcare face ₹134 crore Income Tax demand
Shares of Akums Drugs and Pharmaceuticals Ltd ended at ₹513.00, down by ₹6.70, or 1.29%, on the BSE.
Akums Drugs Q4 profit declines, but EBITDA jumps 62%; declares special dividend
Akums Drugs reported a mixed set of fourth-quarter earnings, with profit declining sharply despite healthy revenue growth and strong margin expansion, while the board announced a final and special dividend.